Search
for

    Sort by

    Research 361–390 of 505

    1. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    2. A Randomised Controlled Trial Comparing the Therapeutic Efficacy and Safety of Oral Cyclosporine and Oral Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata Cureus · 2025
    3. The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology Skin appendage disorders · 2024
    4. TONGUE, RED 2006
    5. Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor Dermatology · 2012 · 19 citations
    6. Acneiform follicular mucinosis Clinical and experimental dermatology · 2004 · 19 citations
    7. Vellus hair cysts presenting as an atypical acneiform eruption Anais Brasileiros de Dermatologia · 2011 · 6 citations
    8. A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$) Linchuang pifuke zazhi · 2004 · 2 citations
    9. Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839 Journal of the American Academy of Dermatology · 2004 · 1 citations
    10. BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata British Journal of Dermatology · 2026
    11. Acneform eruptions with use of minoxidil-a case report International journal of medical research and review · 2016
    12. A Sterile Folliculocentric Acneiform Eruption Mimicking Infection After Hair Transplantation: Clinical Pattern Recognition and a Proposed FUE Epidermal Cap–Angle Mechanism Journal of Cosmetic Dermatology · 2026
    13. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors European journal of cancer · 2007 · 138 citations
    14. Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor Acta Dermato Venereologica · 2003 · 116 citations
    15. Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex Indian Journal of Dermatology · 2014 · 43 citations
    16. Cutaneous side-effects of EGFR inhibitors and their management. PubMed · 2011 · 38 citations
    17. Incidence and management of cutaneous toxicities associated with cetuximab Expert opinion on drug safety · 2007 · 30 citations
    18. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients International Journal of Trichology · 2018 · 24 citations
    19. Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study Indian Journal of Endocrinology and Metabolism · 2012 · 20 citations
    20. Skin toxicity of anti‐cancer therapy Journal der Deutschen Dermatologischen Gesellschaft · 2008 · 19 citations
    21. Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients Dermatologic Therapy · 2019 · 17 citations
    22. Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy Acta Dermato Venereologica · 2010 · 17 citations
    23. Cutaneous Toxicities From Transplantation-Related Medications American Journal of Transplantation · 2017 · 14 citations
    24. Ectopic sebaceous gland: a developmental anomaly Journal of cutaneous pathology · 2006 · 7 citations
    25. Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature Dermatology Online Journal · 2021 · 5 citations
    26. Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis Drug design, development and therapy · 2022 · 4 citations
    27. Severe Pustular Drug Eruptions From Amivantamab: A Case Series International Journal of Dermatology · 2026 · 1 citations
    28. Successful alopecia universalis treatment with the combination of cyclosporine and oral corticosteroid: a case report Bali Medical Journal · 2022 · 1 citations
    29. The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker Indian Journal of Postgraduate Dermatology · 2026
    30. P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution British Journal of Dermatology · 2026